| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lenalidomide | FAERS: 4 | US FAERS | |
| 2 | Furosemide | FAERS: 2 | US FAERS | |
| 3 | Lithium | FAERS: 1 | US FAERS | |
| 4 | Metformin | FAERS: 1 | US FAERS | |
| 5 | Methotrexate | FAERS: 1 | US FAERS | |
| 6 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 7 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 8 | venetoclax | FAERS: 1 | US FAERS | |
| 9 | Cytarabine | OFFSIDES | ||
| 10 | Etoposide | OFFSIDES | ||
| 11 | Ifosfamide | OFFSIDES | ||
| 12 | Leflunomide | OFFSIDES | ||
| 13 | Thiotepa | OFFSIDES | ||
| 14 | fludarabine phosphate | OFFSIDES | ||
| 15 | fludarabine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.